Lesinurad Impurity N Chemical Properties

Density 

1.56±0.1 g/cm3(Predicted)

pka

2.97±0.10(Predicted)

Lesinurad Impurity N Usage And Synthesis

Uses

4-[[5-[(Carboxymethyl)thio]-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]amino]-4-oxo-butanoic Acid is an impurity of drug Lesinurad (L329700), which is used to synthesize febuxostat which is a non-purine analog inhibitor of xanthine oxidase. Febuxostat is approved by the European Medicines Agency and the US Food and Drug Administration for treating gout.

Lesinurad Impurity N(1533519-99-1)Related Product Information

• Lesinurad Impurity 22
• Lesinurad Impurity C1
• N-(4-Cyclopropyl-1-naphthalenyl)-2-formylhydrazinecarbothioamide
• Lesinurad Impurity 2
• Lesinurad Impurity 10
• 1-cyclopropylnaphthalene
• Lesinurad Impurity 4
• 3H-1,2,4-Triazole-3-thione, 5-amino-4-(4-cyclopropyl-1-naphthalenyl)-2,4-dihydro
• NAPHTHALENE, 1-CYCLOPROPYL-4-ISOTHIOCYANATO-
• 3-bromo-4-(4-cyclopropylnaphthalen-1-yl)-1H-1,2,4-triazole-5(4H)-thione
• Lesinurad Impurity J
• Lesinurad M4 Metabolite
• 4-(4-cyclopropylnaphthalen-1-yl)-1H-1,2,4-triazole-5(4H)-thione
• Lesinurad Impurity B
• Lesinurad Impurity L
• Lesinurad Impurity K
• Methyl 2-(5-broMo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetate
• Lesinurad Impurity 5 Sodium Salt